ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and Diagnostic Emergency Use Authorizations in November 2020. Updated December 2.
A roundup of FDA’s actions in November 2020.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and Diagnostic Emergency Use Authorizations in November 2020. Updated December 2.
A roundup of FDA’s actions in November 2020.